• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus.克服医院健康技术评估(HB-HTA)中的障碍:国际专家小组共识
Healthcare (Basel). 2024 Apr 25;12(9):889. doi: 10.3390/healthcare12090889.
2
Barriers and Facilitators to Automated Self-Scheduling: Consensus from a Delphi Panel of Key Stakeholders.自动化自助排班的障碍和促进因素:来自关键利益相关者德尔菲小组的共识。
Perspect Health Inf Manag. 2022 Jan 1;19(1):1m. eCollection 2022 Winter.
3
Recommendations for the Implementation of Hospital Based HTA in Poland: Lessons Learned From International Experience.波兰医院层面卫生技术评估实施建议:国际经验教训
Front Pharmacol. 2021 May 13;11:594644. doi: 10.3389/fphar.2020.594644. eCollection 2020.
4
SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC?国际共享和收集医院的卫生技术评估报告:利益相关者的广泛参与是否现实?
Int J Technol Assess Health Care. 2018 Jan;34(5):527-534. doi: 10.1017/S0266462318000570. Epub 2018 Oct 16.
5
Possibilities of Implementing Hospital-Based Health Technology Assessment (HB-HTA) at the Level of Voivodeship Offices in Poland.在波兰的省一级实施基于医院的卫生技术评估(HB-HTA)的可能性。
Int J Environ Res Public Health. 2022 Sep 7;19(18):11235. doi: 10.3390/ijerph191811235.
6
Most important barriers and facilitators of HTA usage in decision-making in Europe.欧洲卫生技术评估(HTA)在决策过程中最重要的障碍和促进因素。
Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):297-304. doi: 10.1080/14737167.2018.1421459. Epub 2018 Jan 5.
7
GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS.医院健康技术评估单位良好实践指导原则。
Int J Technol Assess Health Care. 2015;31(6):457-65. doi: 10.1017/S0266462315000732. Epub 2016 Feb 22.
8
Relevance of barriers and facilitators in the use of health technology assessment in Colombia.哥伦比亚卫生技术评估使用中障碍与促进因素的相关性
J Med Econ. 2018 May;21(5):510-517. doi: 10.1080/13696998.2018.1449751. Epub 2018 Mar 23.
9
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France.基于医院的创新医疗器械卫生技术评估:法国全国性调查的见解。
Int J Technol Assess Health Care. 2023 Sep 21;39(1):e58. doi: 10.1017/S0266462323000521.
10
MOST IMPORTANT BARRIERS AND FACILITATORS REGARDING THE USE OF HEALTH TECHNOLOGY ASSESSMENT.最重要的是使用卫生技术评估的障碍和促进因素。
Int J Technol Assess Health Care. 2017 Jan;33(2):183-191. doi: 10.1017/S0266462317000290.

引用本文的文献

1
Connecting minds and catalyzing collaboration: the interest groups of health technology assessment international.连接思想,促进合作:国际卫生技术评估兴趣小组
Int J Technol Assess Health Care. 2025 Jul 7;41(1):e43. doi: 10.1017/S0266462325100287.
2
Optimizing Patient Access to Orphan Medicinal Products: Lessons from Central and Eastern Europe.优化患者获取孤儿药的途径:来自中东欧的经验教训。
J Mark Access Health Policy. 2025 May 26;13(2):24. doi: 10.3390/jmahp13020024. eCollection 2025 Jun.
3
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey.基于医院的卫生技术评估的潜力:一项全球调查的结果
Int J Technol Assess Health Care. 2025 Mar 18;41(1):e19. doi: 10.1017/S0266462325000108.
4
Driving policy dialogue on health technology assessment in Eastern Europe and Central Asia: reporting from an initiative of Health Technology Assessment International.推动东欧和中亚地区卫生技术评估政策对话:来自国际卫生技术评估组织一项倡议的报告
Int J Technol Assess Health Care. 2025 Feb 6;41(1):e12. doi: 10.1017/S0266462325000066.

本文引用的文献

1
Introduction of hospital-based health technology assessment in China: experiences from seven pilot hospitals.中国医院为基础的卫生技术评估介绍:来自七个试点医院的经验。
Int J Technol Assess Health Care. 2024 Jan 29;40(1):e20. doi: 10.1017/S0266462323002738.
2
The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum.健康技术评估的价值和影响:2023 年健康技术评估国际全球政策论坛的讨论和建议。
Int J Technol Assess Health Care. 2023 Dec 22;39(1):e75. doi: 10.1017/S0266462323002763.
3
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France.基于医院的创新医疗器械卫生技术评估:法国全国性调查的见解。
Int J Technol Assess Health Care. 2023 Sep 21;39(1):e58. doi: 10.1017/S0266462323000521.
4
The initiation, exploration, and development of hospital-based health technology assessment in China: 2005 ‒ 2022.中国医院卫生技术评估的启动、探索与发展:2005年至2022年
Biosci Trends. 2023 Mar 11;17(1):1-13. doi: 10.5582/bst.2023.01013. Epub 2023 Feb 12.
5
Purchasing high-cost medical devices and equipment in hospitals: a systematic review.医院采购高值医用设备和器械:系统评价。
BMJ Open. 2022 Sep 1;12(9):e057516. doi: 10.1136/bmjopen-2021-057516.
6
Possibilities of Implementing Hospital-Based Health Technology Assessment (HB-HTA) at the Level of Voivodeship Offices in Poland.在波兰的省一级实施基于医院的卫生技术评估(HB-HTA)的可能性。
Int J Environ Res Public Health. 2022 Sep 7;19(18):11235. doi: 10.3390/ijerph191811235.
7
Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe.关于影响欧洲卫生技术评估审议过程的隐性因素的系统文献综述。
J Mark Access Health Policy. 2022 Jun 28;10(1):2094047. doi: 10.1080/20016689.2022.2094047. eCollection 2022.
8
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder.对于两种抗抑郁药物治疗失败的重度抑郁症患者,重复经颅磁刺激可能是一种具有成本效益的替代治疗方法。
BMC Psychiatry. 2022 Jun 28;22(1):437. doi: 10.1186/s12888-022-04078-9.
9
Hospital-Based Health Technology Assessment of Machine Perfusion Systems for Human Liver Transplantation.基于医院的机器灌注系统在人类肝移植中的卫生技术评估。
Transpl Int. 2022 May 27;35:10405. doi: 10.3389/ti.2022.10405. eCollection 2022.
10
Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework.基于医院的卫生技术评估中评估癌症治疗方法的多准则决策分析(MCDA):矛盾价值框架。
PLoS One. 2022 May 25;17(5):e0268584. doi: 10.1371/journal.pone.0268584. eCollection 2022.

克服医院健康技术评估(HB-HTA)中的障碍:国际专家小组共识

Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus.

作者信息

Lipska Iga, Di Bidino Rossella, Niewada Maciej, Nemeth Bertalan, Bochenek Tomasz, Kukla Monika, Więckowska Barbara, Sobczak Alicja, Iłowiecka Katarzyna, Zemplenyi Antal, Martelli Nicolas, Martin Tess, Filiniuk Olena, Kosyachenko Kostyantyn, Sucu Rabia, Piniazhko Oresta, Zaliska Olha, Avdeyev Andrey, Shanazarov Nasrulla, von Pinoci Marina, Hren Rok

机构信息

Health Policy Institute, 00-819 Warsaw, Poland.

Medical Department, Academy of Applied Medical and Social Sciences, 82-300 Elbląg, Poland.

出版信息

Healthcare (Basel). 2024 Apr 25;12(9):889. doi: 10.3390/healthcare12090889.

DOI:10.3390/healthcare12090889
PMID:38727447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11083158/
Abstract

The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Kazakhstan, Poland, Switzerland, and Ukraine. Experts initially conducted a comprehensive review of the HB-HTA implementation in their respective countries, identifying the barriers and facilitators through descriptive analysis. Subsequently, panel experts ranked these identified barriers and facilitators on a seven-point Likert scale. A median agreement score ≥ 6 and interquartile range (IQR) ≤ 1 was accepted as reaching a consensus. Out of the 12 statements categorized as external and internal barriers and facilitators, the expert panel reached consensus on six statements (two barriers and four facilitators). The external barrier, which achieved consensus, was the lack of the formal recognition of the role of HB-HTA in national or regional legislations. The internal barrier reaching consensus was the limited availability of human resources dedicated to HB-HTA. This qualitative study indicates that HB-HTA still has progress to make before being formally accepted and integrated across most countries, although by building on the facilitating factors we identified there may be an opportunity for the implementation of internationally developed strategies to strengthen HB-HTA practices.

摘要

本文旨在调查在七个国家不同医院环境中实施基于医院的卫生技术评估(HB-HTA)的常见促进因素和障碍。通过两轮德尔菲研究,从来自法国、匈牙利、意大利、哈萨克斯坦、波兰、瑞士和乌克兰的15名卫生技术评估专家小组中收集了意见。专家们首先对各自国家的HB-HTA实施情况进行了全面审查,通过描述性分析确定了障碍和促进因素。随后,专家小组对这些确定的障碍和促进因素按照七点李克特量表进行排名。中位数一致得分≥6且四分位间距(IQR)≤1被视为达成共识。在归类为外部和内部障碍及促进因素的12条陈述中,专家小组对6条陈述(2条障碍和4条促进因素)达成了共识。达成共识的外部障碍是HB-HTA在国家或地区立法中的作用缺乏正式认可。达成共识的内部障碍是专门用于HB-HTA的人力资源有限。这项定性研究表明,在大多数国家正式接受并整合HB-HTA之前,它仍有进步空间,不过基于我们确定的促进因素,或许有机会实施国际制定的战略来加强HB-HTA实践。